I am 48, male. How to manage ADPKD and stage 3 CKD?

Hi,

Welcome to icliniq.com.

I understand your concern.

You are describing a classic picture of autosomal dominant polycystic kidney disease (ADPKD) that has now progressed to stage 3 chronic kidney disease (CKD). This inherited disorder causes fluid-filled cysts to gradually enlarge in both kidneys, compressing normal tissue and leading to declining kidney function. Pain, hematuria, and high blood pressure are common as the cysts expand. The small liver cysts you mentioned are also part of the same disease process.

Your rising creatinine (from 1.4 to 2.3 mg/dL) and eGFR (glomerular filtration rate) of 42 indicate moderate kidney impairment. Controlling blood pressure, staying hydrated, and avoiding kidney toxins such as NSAIDs (non-steroidal anti-inflammatory drugs) and contrast dyes are vital to slow further deterioration.

Tolvaptan, a V2-receptor antagonist, is currently the only approved disease-modifying therapy that can slow cyst growth and the decline in kidney function in patients with rapidly progressing ADPKD. You may qualify for this treatment if you are under 55 years old, have an eGFR above 25 mL/min, and imaging shows large kidney volume or rapid progression. However, it requires careful monitoring because it can cause increased urination and thirst due to water loss, liver enzyme elevation (which requires regular blood tests every one to three months), and mild dehydration if fluids are not adequately maintained. Your nephrologist can perform a Mayo imaging classification (based on kidney size) to assess eligibility.

Maintaining tight blood pressure control (goal <130/80 mmHg) is important, and you may need a higher losartan dose or an additional antihypertensive. It is also recommended to stay well hydrated (around three liters per day unless you have a heart condition that limits fluid intake), limit salt and protein intake, and avoid caffeine, as it can stimulate cyst growth. Pain should be managed conservatively by avoiding NSAIDs and using Acetaminophen instead. If pain persists due to very large cysts, interventional radiology procedures for cyst drainage may be considered. It is also essential to monitor for complications such as recurrent infections, kidney stones, or cyst bleeding.

Worldwide studies are exploring new treatment options such as somatostatin analogs (Octreotide, Lanreotide), which may help slow cyst expansion in some patients, and other agents like Metformin and mTOR (mechanistic target of Rapamycin) inhibitors, which are still under research. Your nephrologist can help identify regional or national clinical trials suited to your stage of disease.

With good control of blood pressure and the use of Tolvaptan, if eligible, disease progression can be significantly slowed, often delaying the need for dialysis or a kidney transplant by several years.

I hope this has helped you.

Please feel free to reach out to me again for further queries.

Thank you.